Invention Grant
- Patent Title: Sulfonyl compounds which modulate the CB2 receptor
- Patent Title (中): 调节CB2受体的磺酰基化合物
-
Application No.: US13809607Application Date: 2011-07-18
-
Publication No.: US08846936B2Publication Date: 2014-09-30
- Inventor: Eugene Richard Hickey , Doris Riether , Monika Ermann
- Applicant: Eugene Richard Hickey , Doris Riether , Monika Ermann
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- International Application: PCT/US2011/044309 WO 20110718
- International Announcement: WO2012/012307 WO 20120126
- Main IPC: C07D213/72
- IPC: C07D213/72 ; C07D213/78 ; C07D261/04 ; C07D261/14 ; C07D231/00 ; A01N43/40 ; A01N43/80 ; A61K31/44 ; A61K31/42 ; C07D277/46 ; C07D285/135 ; C07D213/74 ; C07D413/12 ; C07D261/18 ; C07D231/38
Abstract:
Compounds of formula (I) and formula (II) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20130184315A1 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Public/Granted day:2013-07-18
Information query
